Nuwellis (NUWE) Net Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,901.00 |
| Dec 31, 2025 | -12,103.00 |
| Sep 30, 2025 | 74,881.00 |
| Jun 30, 2025 | -56,941.00 |
| Mar 31, 2025 | -9,502.00 |
| Dec 31, 2024 | -16,284.00 |
| Sep 30, 2024 | 45,172.00 |
| Jun 30, 2024 | -14,806.00 |
| Mar 31, 2024 | 10,670.00 |
| Dec 31, 2023 | -17,102.00 |
| Sep 30, 2023 | 9,378.00 |
| Jun 30, 2023 | 12,165.00 |
| Mar 31, 2023 | -89,658.00 |
| Dec 31, 2022 | 72,884.00 |
| Sep 30, 2022 | 626.00 |
| Jun 30, 2022 | 3,857.00 |
| Mar 31, 2022 | 3,371.00 |
| Dec 31, 2021 | 1,856.00 |
| Sep 30, 2021 | -9,588.00 |
| Jun 30, 2021 | 8,357.00 |
| Mar 31, 2021 | -11,981.00 |
| Dec 31, 2020 | 7,134.00 |
| Sep 30, 2020 | -1,322.00 |
| Jun 30, 2020 | 6,972.00 |
| Mar 31, 2020 | 4,572.00 |
| Dec 31, 2019 | 3,417.00 |
| Sep 30, 2019 | -9,598.00 |
| Jun 30, 2019 | 12,489.00 |
| Mar 31, 2019 | -10,513.00 |
| Dec 31, 2018 | 2,723.00 |
| Sep 30, 2018 | 6,928.00 |
| Jun 30, 2018 | 3,943.00 |
| Mar 31, 2018 | 43,790.00 |
| Dec 31, 2017 | -56,027.00 |
| Sep 30, 2017 | -1,300.00 |
| Jun 30, 2017 | -18,016.00 |
| Mar 31, 2017 | 28,455.00 |
| Dec 31, 2016 | 33,249.00 |
| Mar 31, 2015 | -816,158.00 |
| Dec 31, 2014 | 658,362.00 |